Research progress on preclinical pharmacodynamics of personalized therapeutic tumor vaccinesHE Qing, GAO Hua, WANG Jun-zhi2401-2409
Research progress on DNA vaccines against SARS-CoV-2JIN Xiang, YU Qing-ling, ZHANG Lu-nan, HE Yue, CHENG Xin, LIU Xiao-yan, WANG Bin2425-2433
Escherichia coli expression system applied in the development of recombinant human vaccines and its potential improvementLIU Li-qin, CHEN Ting-ting, LI Shao-wei, XIA Ning-shao2434-2442
Development and industrialization of TCR-T cell therapyRUI Wei, LIU Guang-na, TONG Dan, JI Liang-liang, CHEN Xiao-yuan, ZHAO Xue-qiang, LIN Xin2443-2449
Emerging infectious diseases and new vaccine technologiesYANG Hui-qiang, LIU Lan-jun, GE Yong-hong2450-2458
The submission status and considerations for pharmaceutical researches of human papillomavirus vaccineREN Hui-mei, LI Min, LUO Jian-hui2465-2469
Consideration of basic technical requirements for pharmaceutical research of insulin and its analoguesCHENG Su-yuan, SAI Wen-bo, WEI Kai-kun, LUO Jian-hui2470-2475
Consideration on similarity assessment of glycosylation of biosimilar productZHANG Zhong-bing, WEI Wei, LUO Jian-hui2476-2480